CONTOLI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 10.079
EU - Europa 3.208
AS - Asia 2.798
SA - Sud America 467
AF - Africa 38
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 16.615
Nazione #
US - Stati Uniti d'America 10.008
SG - Singapore 1.253
CN - Cina 930
IT - Italia 882
DE - Germania 627
UA - Ucraina 482
BR - Brasile 420
FI - Finlandia 295
TR - Turchia 295
GB - Regno Unito 267
SE - Svezia 212
PL - Polonia 162
ID - Indonesia 128
FR - Francia 86
HK - Hong Kong 63
NL - Olanda 46
CA - Canada 44
BE - Belgio 27
AT - Austria 23
VN - Vietnam 22
CZ - Repubblica Ceca 21
IN - India 21
AR - Argentina 20
JP - Giappone 20
MX - Messico 19
ZA - Sudafrica 19
LT - Lituania 17
RU - Federazione Russa 17
BD - Bangladesh 15
AU - Australia 13
IQ - Iraq 9
ES - Italia 8
UZ - Uzbekistan 8
PE - Perù 7
CO - Colombia 6
MA - Marocco 6
VE - Venezuela 6
HU - Ungheria 5
IR - Iran 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
TN - Tunisia 5
CH - Svizzera 4
EC - Ecuador 4
EU - Europa 4
MK - Macedonia 4
AL - Albania 3
AZ - Azerbaigian 3
DZ - Algeria 3
IE - Irlanda 3
RO - Romania 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
CL - Cile 2
EG - Egitto 2
GE - Georgia 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
OM - Oman 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
MD - Moldavia 1
NO - Norvegia 1
PA - Panama 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
UY - Uruguay 1
Totale 16.615
Città #
Fairfield 1.248
Woodbridge 1.044
Houston 956
Ashburn 622
Santa Clara 602
Singapore 584
Jacksonville 557
Chandler 537
Ann Arbor 508
Wilmington 491
Seattle 486
Cambridge 426
Munich 271
Beijing 236
Izmir 187
Ferrara 184
Nanjing 177
Princeton 169
Warsaw 156
Milan 132
Jakarta 125
Helsinki 121
New York 116
Los Angeles 103
San Diego 103
Boardman 89
Shanghai 83
Addison 64
Hong Kong 60
Dearborn 55
Chicago 54
Nanchang 49
Turku 49
Shenyang 47
London 45
São Paulo 38
Mountain View 35
Washington 35
Rome 34
Tianjin 31
Bologna 30
Changsha 30
Hebei 30
Jiaxing 29
Redwood City 28
Frankfurt am Main 27
Brussels 26
Falls Church 26
The Dalles 26
Council Bluffs 25
Jinan 22
Norwalk 22
Bremen 19
Nuremberg 19
Toronto 19
Orange 18
Salt Lake City 18
Tokyo 17
Dong Ket 16
Kunming 16
San Francisco 16
Brno 15
Guangzhou 15
Verona 15
Lappeenranta 14
Dallas 13
Naples 13
Taizhou 13
Zhengzhou 13
Brooklyn 12
Des Moines 12
Auburn Hills 11
Belo Horizonte 11
Ningbo 11
Parma 11
Augusta 10
Falkenstein 10
Florence 10
Jyväskylä 10
Rio de Janeiro 10
San Mateo 10
Campinas 9
Paris 9
Vienna 9
Atlanta 8
Boston 8
Ferrara di Monte Baldo 8
Istanbul 8
Lanzhou 8
Ottawa 8
Philadelphia 8
Redmond 8
Brasília 7
Buffalo 7
Goiânia 7
Johannesburg 7
Tashkent 7
Catania 6
Elk Grove Village 6
Hefei 6
Totale 11.771
Nome #
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 339
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 279
Targeting Th2 cells in asthmatic airways 242
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio. 239
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 222
Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients 204
The contribution of small-Airway abnormalities in chronic obstructive pulmonary disease clinical manifestations: More than a functional issue 200
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 196
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 192
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 183
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 168
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 166
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 161
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 160
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 156
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 156
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 151
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 148
Models of infection and exacerbations in COPD. 145
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 145
Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation 144
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 143
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 142
Rhinovirus vaccination: the case against 140
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 136
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. 135
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 134
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 131
Reducing Agents Decrease the Oxidative Burst and Improve Clinical Outcomes in COPD Patients: A Randomised Controlled Trial on the Effects of Sulphurous Thermal Water Inhalation. 131
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 129
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 129
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 127
null 126
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 125
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 124
Is Peripheral Oxygen Saturation a Reliable Predictor of Upper Airways Air-Flow Limitation? 123
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 122
Anti-SARS-Cov-2 IgA response in tears of COVID-19 patients 122
null 121
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 119
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 119
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 118
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 118
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 117
IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma 116
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 114
null 114
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations 114
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 113
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 112
Small airway disease in asthma: pathophysiological and diagnostic considerations 110
Models of respiratory infections: Virus-induced asthma exacerbations and beyond 110
When asthma diagnosis becomes a challenge 109
A simple method for home exercise training in patients with chronic obstructive pulmonary disease: One-year study 109
Bronchial epithelial cells from asthmatic children have a deficient innate immune response to rhinovirus infection 109
ELEMENTI DI VALUTAZIONE E DIAGNOSTICA FUNZIONALE DELL’APPARATO RESPIRATORIO 108
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 107
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 106
Cellule staminali e patologia polmonare dell’adulto 104
γδT cells suppress inflammation and disease during rhinovirus-induced asthma exacerbations. 104
Asthma: A Chronic Infectious Disease? 104
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 104
Interactions of airway pathogens and inflammatory processes 104
Interleukin-4 Modulates Rhinovirus Replication and Antiviral Immune Response in Respiratory Epithelial Cells 103
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease 103
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 103
null 102
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 101
Mechanisms of respiratory virus-induced asthma exacerbations 100
Rhinovirus-induced bronchial mucosal inflammatory response in asthma 100
Increased deposition of activated complement in peripheral lung vessels of smokers 100
Midazolam in flexible bronchoscopy premedication: effects on patient-related and procedure-related outcomes. 99
Do small airway abnormalities characterize asthma phenotypes? In search of proof. 97
Neutrophil adhesion molecules in experimental rhinovirus infection in COPD. 97
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine 97
Rhinovirus-induced interferon production in asthma 96
Effects of Anti-IL-5 on Virus-induced Exacerbation in Asthma Light and Shadow 96
Effects of aclidinium on determinants of COPD severity: Symptoms and quality of life 95
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 94
Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up 94
Pathophysiology of viral-induced exacerbations of COPD 92
Deficient immune response to viral infections in children predicts later Asthma persistence 92
Interactions of airway pathogens and inflammatory processes 92
Disease awareness in patients with COPD: measurement and extent 91
A framework for step down or therapeutic re-organization for withdrawal of inhaled corticosteroids in selected patients with COPD: A proposal for COPD management 91
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 91
null 90
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 89
Update in asthma 2016 89
A serum proteome signature to predict mortality in severe COVID-19 patients 89
The small airways and distal lung compartment in asthma and COPD: A time for reappraisal 88
null 88
null 87
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 85
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients 85
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 85
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 83
null 83
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 83
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 82
Totale 12.430
Categoria #
all - tutte 98.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.102
Totale 101.355


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202075 0 0 0 0 0 0 0 0 0 0 0 75
2020/20212.212 126 132 170 247 155 181 103 261 74 305 266 192
2021/20221.529 74 125 108 140 56 80 85 98 65 116 160 422
2022/20231.438 185 62 69 145 205 192 107 117 174 26 104 52
2023/2024980 74 107 48 29 59 170 38 68 34 34 49 270
2024/20254.603 100 107 363 166 530 446 208 290 833 523 596 441
Totale 17.026